These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24901376)

  • 1. Octaarginine-modified liposomes enhance cross-presentation by promoting the C-terminal trimming of antigen peptide.
    Nakamura T; Ono K; Suzuki Y; Moriguchi R; Kogure K; Harashima H
    Mol Pharm; 2014 Aug; 11(8):2787-95. PubMed ID: 24901376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes.
    Nakamura T; Moriguchi R; Kogure K; Shastri N; Harashima H
    Mol Ther; 2008 Aug; 16(8):1507-14. PubMed ID: 18560420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of polyinosine-polycytidylic acid enhances cytotoxic T cell activity and antitumor effects by octaarginine-modified liposomes encapsulating antigen, but not by octaarginine-modified antigen complex.
    Nakamura T; Moriguchi R; Kogure K; Harashima H
    Int J Pharm; 2013 Jan; 441(1-2):476-81. PubMed ID: 23159346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced antigen presentation and CTL activity by transduction of mature rather than immature dendritic cells with octaarginine-modified liposomes.
    Homhuan A; Kogure K; Nakamura T; Shastri N; Harashima H
    J Control Release; 2009 May; 136(1):79-85. PubMed ID: 19344678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects.
    Miura N; Akita H; Tateshita N; Nakamura T; Harashima H
    Mol Ther; 2017 Apr; 25(4):1003-1013. PubMed ID: 28236573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular heat shock protein 90 plays a role in translocating chaperoned antigen from endosome to proteasome for generating antigenic peptide to be cross-presented by dendritic cells.
    Oura J; Tamura Y; Kamiguchi K; Kutomi G; Sahara H; Torigoe T; Himi T; Sato N
    Int Immunol; 2011 Apr; 23(4):223-37. PubMed ID: 21421737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles.
    Shen H; Ackerman AL; Cody V; Giodini A; Hinson ER; Cresswell P; Edelson RL; Saltzman WM; Hanlon DJ
    Immunology; 2006 Jan; 117(1):78-88. PubMed ID: 16423043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape.
    El-Sayed A; Khalil IA; Kogure K; Futaki S; Harashima H
    J Biol Chem; 2008 Aug; 283(34):23450-61. PubMed ID: 18550548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KALA-modified multi-layered nanoparticles as gene carriers for MHC class-I mediated antigen presentation for a DNA vaccine.
    Shaheen SM; Akita H; Nakamura T; Takayama S; Futaki S; Yamashita A; Katoono R; Yui N; Harashima H
    Biomaterials; 2011 Sep; 32(26):6342-50. PubMed ID: 21658761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cell-penetrating peptide-assisted nanovaccine promotes antigen cross-presentation and anti-tumor immune response.
    Liu X; Liu J; Liu D; Han Y; Xu H; Liu L; Leng X; Kong D
    Biomater Sci; 2019 Dec; 7(12):5516-5527. PubMed ID: 31670734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nanoparticulation by octaarginine-modified liposome improves α-galactosylceramide-mediated antitumor therapy via systemic administration.
    Nakamura T; Yamazaki D; Yamauchi J; Harashima H
    J Control Release; 2013 Oct; 171(2):216-24. PubMed ID: 23860186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens.
    Gao J; Ochyl LJ; Yang E; Moon JJ
    Int J Nanomedicine; 2017; 12():1251-1264. PubMed ID: 28243087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRAP identifies an endosomal compartment required for MHC class I cross-presentation.
    Saveanu L; Carroll O; Weimershaus M; Guermonprez P; Firat E; Lindo V; Greer F; Davoust J; Kratzer R; Keller SR; Niedermann G; van Endert P
    Science; 2009 Jul; 325(5937):213-7. PubMed ID: 19498108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New packaging method of mycobacterial cell wall using octaarginine-modified liposomes: enhanced uptake by and immunostimulatory activity of dendritic cells.
    Homhuan A; Kogure K; Akaza H; Futaki S; Naka T; Fujita Y; Yano I; Harashima H
    J Control Release; 2007 Jul; 120(1-2):60-9. PubMed ID: 17467840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
    El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
    J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat shock proteins in antigen trafficking--implications on antigen presentation to T cells.
    Udono H; Ichiyanagi T; Mizukami S; Imai T
    Int J Hyperthermia; 2009 Dec; 25(8):617-25. PubMed ID: 19551545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitated antigen uptake and timed exposure to TLR ligands dictate the antigen-presenting potential of plasmacytoid DCs.
    Kool M; Geurtsvankessel C; Muskens F; Madeira FB; van Nimwegen M; Kuipers H; Thielemans K; Hoogsteden HC; Hammad H; Lambrecht BN
    J Leukoc Biol; 2011 Dec; 90(6):1177-90. PubMed ID: 21934071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient cross-presentation of soluble exogenous antigens introduced into dendritic cells using a weak-based amphiphilic peptide.
    Ikeuchi N; Futami J; Hosoi A; Noji S; Kurachi M; Ueha S; Fujii S; Yamada H; Matsushima K; Moriyasu F; Kakimi K
    Biochem Biophys Res Commun; 2010 Feb; 392(2):217-22. PubMed ID: 20067764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular fate of octaarginine-modified liposomes in polarized MDCK cells.
    Fujiwara T; Akita H; Harashima H
    Int J Pharm; 2010 Feb; 386(1-2):122-30. PubMed ID: 19922779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.